Published in Trans Am Ophthalmol Soc on January 01, 2004
Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2012) 2.19
Posterior to the ridge laser treatment for severe stage 3 retinopathy of prematurity. Eye (Lond) (2013) 1.44
A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity. Trans Am Ophthalmol Soc (2006) 1.38
The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years. Br J Ophthalmol (2006) 1.27
Telemedicine for retinopathy of prematurity diagnosis: evaluation and challenges. Surv Ophthalmol (2009) 1.16
High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis. Pediatrics (2010) 1.16
Clinical characteristics of children with severe visual impairment but favorable retinal structural outcomes from the Early Treatment for Retinopathy of Prematurity (ETROP) study. J AAPOS (2013) 1.10
Technical aspects of laser treatment for acute retinopathy of prematurity under topical anesthesia. Indian J Ophthalmol (2010) 1.06
Computer-based image analysis for plus disease diagnosis in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus (2011) 1.03
Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability. J Ophthalmol (2011) 1.02
Retinopathy of prematurity: Recommendations for screening. Paediatr Child Health (2010) 0.98
Emerging treatments for retinopathy of prematurity. Semin Ophthalmol (2009) 0.93
Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice. Blood (2011) 0.92
Outcomes of 957 preterm neonatal fundus examinations in a Guangzhou NICU through 2008 to 2011. Int J Ophthalmol (2012) 0.89
Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes. Eye (Lond) (2014) 0.89
Real-time, computer-assisted quantification of plus disease in retinopathy of prematurity at the bedside. Ophthalmic Surg Lasers Imaging Retina (2014) 0.86
Long term visual outcomes in laser treated threshold retinopathy of prematurity in Central Saudi Arabia. Saudi J Ophthalmol (2012) 0.86
Educational paper: Retinopathy of prematurity. Eur J Pediatr (2011) 0.79
The use of digital imaging in the identification of skip areas after laser treatment for retinopathy of prematurity and its implications for education and patient care. Retina (2013) 0.79
Practice Patterns in Retinopathy of Prematurity Treatment for Disease Milder Than Recommended by Guidelines. Am J Ophthalmol (2015) 0.79
Postnatal weight gain in the first two weeks as a predicting factor of severe retinopathy of prematurity requiring treatment. Korean J Pediatr (2015) 0.78
Incidence of Retinopathy of Prematurity in Bahrain, 2002-2011. Middle East Afr J Ophthalmol (2015) 0.78
ROP surgery and ocular circulation. Eye (Lond) (2008) 0.78
Laser treatment for retinopathy of prematurity. Lasers Med Sci (2011) 0.78
COMPARISON OF INTRAVITREAL INJECTION OF RANIBIZUMAB VERSUS LASER THERAPY FOR ZONE II TREATMENT-REQUIRING RETINOPATHY OF PREMATURITY. Retina (2017) 0.78
Retinopathy of prematurity in infants born before 25 weeks gestation in a Korean single neonatal intensive care unit: incidence, natural history and risk factors. J Korean Med Sci (2012) 0.78
Retinopathy of prematurity blindness worldwide: phenotypes in the third epidemic. Eye Brain (2016) 0.77
Risk factors for retinopathy of prematurity: insights from outlier infants. Graefes Arch Clin Exp Ophthalmol (2014) 0.77
Rapid onset anterior segment complication following diode laser photocoagulation for retinopathy of prematurity: a case report. Wideochir Inne Tech Maloinwazyjne (2012) 0.77
Choroidal thickness in regressed retinopathy of prematurity. Eye (Lond) (2014) 0.77
Refractive status of Chinese with laser-treated retinopathy of prematurity. Optom Vis Sci (2015) 0.77
Type 1 Retinopathy of Prematurity and Its Laser Treatment of Large Preterm Infants in East China. PLoS One (2015) 0.77
Sildenafil attenuates vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity. Invest Ophthalmol Vis Sci (2014) 0.76
Where is the junction of zone 2 and zone 3 temporal retina in RetCam images of acute retinopathy of prematurity? Eye (Lond) (2015) 0.75
Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage. J Ophthalmol (2016) 0.75
Retinopathy of prematurity: A comprehensive risk analysis for prevention and prediction of disease. PLoS One (2017) 0.75
Refractive outcome of prethreshold retinopathy of prematurity treated by diode laser: follow-up at 5 years. Clin Ophthalmol (2015) 0.75
The Relationship of Novel Plasma Proteins in the Early Neonatal Period With Retinopathy of Prematurity. Invest Ophthalmol Vis Sci (2016) 0.75
Late-onset Circulatory Collapse and Continuous Positive Airway Pressure are Useful Predictors of Treatment-requiring Retinopathy of Prematurity: A 9-year Retrospective Analysis. Sci Rep (2017) 0.75
Intravitreal Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity: Several Years On. Asia Pac J Ophthalmol (Phila) (2015) 0.75
IGF-1 in retinopathy of prematurity, a CNS neurovascular disease. Early Hum Dev (2016) 0.75
Screening for retinopathy of prematurity: a report from upper Egypt. Int J Ophthalmol (2016) 0.75
Vascular changes on fluorescein angiography of premature infants with low risk of retinopathy of prematurity after high oxygen exposure. Int J Retina Vitreous (2017) 0.75
Spontaneous regression of retinopathy of prematurity: incidence and predictive factors. Int J Ophthalmol (2013) 0.75
A safety and feasibility study of the use of 670 nm red light in premature neonates. J Perinatol (2015) 0.75
In Vivo Angiography Quantifies Oxygen-Induced Retinopathy Vascular Recovery. Optom Vis Sci (2016) 0.75
Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial. Pediatr Res (2016) 0.75
Transpupillary Diode Laser Retinal Photocoagulation for the Treatment of Retinopathy of Prematurity: Experience in Southern Iran. Iran J Med Sci (2016) 0.75
Macular Development in Aggressive Posterior Retinopathy of Prematurity. Biomed Res Int (2015) 0.75
Posterior pole sparing laser photocoagulation combined with intravitreal bevacizumab injection in posterior retinopathy of prematurity. J Ophthalmol (2014) 0.75
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial. BMC Pediatr (2017) 0.75
Characteristics and outcomes of anterior hyaloidal fibrovascular proliferation in lasered retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Study (ITCROPS) report number 4. Int Ophthalmol (2013) 0.75
New insights in diagnosis and treatment for Retinopathy of Prematurity. Int Ophthalmol (2016) 0.75
Ocular Adverse Effects of Intravitreal Bevacizumab Are Potentiated by Intermittent Hypoxia in a Rat Model of Oxygen-Induced Retinopathy. J Ophthalmol (2017) 0.75
Current screening and treatments in retinopathy of prematurity in the US. Eye Brain (2016) 0.75
Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol (2003) 14.41
New visual acuity charts for clinical research. Am J Ophthalmol (1982) 12.72
The Denver developmental screening test. J Pediatr (1967) 6.42
An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol (1984) 6.12
Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol (1988) 4.66
Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology (1991) 3.27
Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol (2001) 3.23
The natural ocular outcome of premature birth and retinopathy. Status at 1 year. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol (1994) 2.56
Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol (2003) 2.37
Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization. Arch Ophthalmol (1996) 2.05
Multicenter trial of early treatment for retinopathy of prematurity: study design. Control Clin Trials (2004) 1.94
Assessment of visual acuity in infants and children: the acuity card procedure. Dev Med Child Neurol (1986) 1.73
Monocular acuity norms for the Teller Acuity Cards between ages one month and four years. Invest Ophthalmol Vis Sci (1995) 1.64
Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome--structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol (1990) 1.63
Large sample population age norms for visual acuities obtained with Vistech-Teller Acuity Cards. Invest Ophthalmol Vis Sci (1995) 1.60
The multicenter study of Early Treatment for Retinopathy of Prematurity (ETROP). Ophthalmology (2001) 1.57
The acuity card procedure: a rapid test of infant acuity. Invest Ophthalmol Vis Sci (1985) 1.38
Early treatment of posterior retinopathy of prematurity: a controlled trial. Ophthalmology (1997) 1.30
Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Pediatrics (2000) 1.12
Laser treatment of zone I prethreshold and stage 3 threshold retinopathy of prematurity. J Pediatr Ophthalmol Strabismus (2003) 1.05
Children with blindness due to retinopathy of prematurity: a population-based study. Perinatal data, neurological and ophthalmological outcome. Dev Med Child Neurol (1998) 1.03
Acuity card assessment of visual function in the cryotherapy for retinopathy of prematurity trial. Invest Ophthalmol Vis Sci (1990) 1.02
Agreement between grating acuity at age 1 year and Snellen acuity at age 5.5 years in the preterm child. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Invest Ophthalmol Vis Sci (1999) 0.99
The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics (2005) 2.65
Multicenter trial of early treatment for retinopathy of prematurity: study design. Control Clin Trials (2004) 1.94
The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years. Br J Ophthalmol (2006) 1.27
Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age. Ophthalmology (2008) 1.22
Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age. J AAPOS (2013) 1.21
Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity. Ophthalmology (2005) 1.21
Astigmatism in the Early Treatment for Retinopathy Of Prematurity Study: findings to 3 years of age. Ophthalmology (2008) 1.09
Astigmatism progression in the early treatment for retinopathy of prematurity study to 6 years of age. Ophthalmology (2011) 0.99
Prevalence and course of strabismus in the first year of life for infants with prethreshold retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity study. Arch Ophthalmol (2006) 0.88
Visual field extent at 6 years of age in children who had high-risk prethreshold retinopathy of prematurity. Arch Ophthalmol (2011) 0.87
Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial. J AAPOS (2011) 0.86
The early treatment for ROP (ETROP) randomized trial: study results and nursing care adaptations. Insight (2005) 0.84
Incidence of cataract development by 6 months' corrected age in the Early Treatment for Retinopathy of Prematurity study. J AAPOS (2013) 0.84
Progression of type 2 to type 1 retinopathy of prematurity in the Early Treatment for Retinopathy of Prematurity Study. Arch Ophthalmol (2010) 0.77
Grating visual acuity results in the early treatment for retinopathy of prematurity study. Arch Ophthalmol (2011) 0.76